The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy
Crossref DOI link: https://doi.org/10.1007/s12325-017-0491-1
Published Online: 2017-02-16
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Meece, Jerry
Funding for this research was provided by:
AstraZeneca
License valid from 2017-02-16